相关实验视频

Updated: Jan 8, 2026

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

由酶指导:作为精准医学战略的向光动力疗法

Lara Sereina Wild¹, Joel Whitcher², Thibaud Rossel³

¹Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, Paris 75005, France. lara.wild@chimieparistech.psl.eu.

|December 23, 2025

概括

以酶为向的光动力学疗法 (PDT) 使用与酶抑制剂相关的基于金属的光敏化剂,用于精确的癌症治疗. 这种双重作用的方法增强了瘤的破坏,并阻断了前瘤信号通路,改善了患者的治疗结果.

科学领域:

在瘤学瘤学.
照相医疗 (photomedicine) 是一种医学.
生物化学生物化学

背景情况:

光动力疗法 (PDT) 是一种具有可控细胞毒性的非侵入性癌症治疗方法.
目前的光敏感剂 (PSs) 往往缺乏瘤特异性,限制了PDT的疗效.
向性PDT (tPDT) 旨在通过将PSs导向瘤组织来提高特异性.

研究的目的:

审查向酶的tPDT策略,使用与酶抑制剂结合的金属基PS.
探索瘤破坏和途径抑制的双重作用机制.
为了突出这种方法在不同酶标的多功能性.

主要方法:

关于向酶的tPDT的文献综述.
专注于与小分子酶抑制剂结合的基于金属的PS.
涉及碳酸酶 (CA),甲素B,环氧化原酶 (COX),表皮生长因子受体 (EGFR) 和热冲击蛋白90 (Hsp90) 抑制剂的案例研究.

主要成果:

与酶抑制剂结合的金属基PS显示出双作用能力.
成功准和抑制参与瘤生长的特定酶.
对各种与癌症相关的蛋白质的酶导向tPDT的多功能性已被证明.

结论:

酶导向的tPDT提供了增强的瘤特异性和治疗疗效.
这种方法最大限度地减少了非目标毒性和附带损害,提高了患者的安全性.
用酶向的tPDT集成了针对性治疗,光疗法和精确瘤学,用于晚期癌症治疗.

关键词:

酶抑制剂是一种酶抑制剂.医学无机化学医学无机化学光动力疗法 (PDT) 是一种光动力疗法.光敏化剂光敏化剂精准医学是一门精准的医学.

更多相关视频

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation

Published on: January 24, 2025

Development of an Innovative LED-based Illumination Device for In Vitro Application of Photodynamic Therapy with Rose Bengal

Development of an Innovative LED-based Illumination Device for In Vitro Application of Photodynamic Therapy with Rose Bengal

Published on: September 12, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...